BIOCRYST PHARM (BO1) : Analyse, Valorisation, Dividende et Ratios Financiers

BIOCRYST PHARM

BO1StockBE

€—

B

BIOCRYST PHARM

€—

BO1StockBE

Arberion© 2026

Arberion

Loading market data